• (前)Bain & Company
  • Seoul National University Business School, B.A.
  • (前)Bain & Company
  • Seoul National University Business School, B.A.

“I was in business development team when I first came to Voronoi and now I am in overseas IR team. I would like to describe about both works today.

Voronoi is a biotech company who focuses on R&D of innovative drugs. Yes, we do make novel drugs and lead preclinical and clinical trials. Our core strategy is to license out our assets during early clinical trial phases. Business development team is in a charge of these “license out deals.” BD team keeps researching about market landscape, big pharma companies’ movements, and leads many meetings with them. BD team basically leads A to Z process for successful licensing out.

Overseas IR team, as you can sense from words, leads meetings with overseas investors. There are many venture capitals and investors who are interested in investing biotech sectors. Overseas IR team leads the discussion with them.

There are many interesting points about my jobs and roles. Firstly, both roles provide me with many opportunities to work with overseas counterpart and this new experience is giving me many lessons every day. Also, I handle many kinds of stakeholders from big pharma companies, to investors and venture capitals and this also gives me many lessons.

See you soon in Voronoi!”

“I was in business development team when I first came to Voronoi and now I am in overseas IR team. I would like to describe about both works today.

Voronoi is a biotech company who focuses on R&D of innovative drugs. Yes, we do make novel drugs and lead preclinical and clinical trials. Our core strategy is to license out our assets during early clinical trial phases. Business development team is in a charge of these “license out deals.” BD team keeps researching about market landscape, big pharma companies’ movements, and leads many meetings with them. BD team basically leads A to Z process for successful licensing out.

Overseas IR team, as you can sense from words, leads meetings with overseas investors. There are many venture capitals and investors who are interested in investing biotech sectors. Overseas IR team leads the discussion with them.

There are many interesting points about my jobs and roles. Firstly, both roles provide me with many opportunities to work with overseas counterpart and this new experience is giving me many lessons every day. Also, I handle many kinds of stakeholders from big pharma companies, to investors and venture capitals and this also gives me many lessons.

See you soon in Voronoi!”